Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: The California teachers study

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Clague, Jessica ^a   Reynolds, Peggy ^b   Henderson, Katherine D ^a   Sullivan Halley, Jane ^a   Ma, Huiyan ^a   Lacey Jr , James V ^a   Chang, Shine ^c   Delclos, George L ^c   Du, Xianglin L ^c   Forman, Michele R ^d   Bernstein, Leslie ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; ESTROGEN THERAPY; FEMALE; HORMONAL THERAPY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MENOPAUSAL HORMONE THERAPY; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SURVIVAL TIME; TREATMENT DURATION; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MORTALITY; PROPORTIONAL HAZARDS MODEL; UNITED STATES; UNIVERSITY;

CALIFORNIA; CARCINOMA, NON-SMALL-CELL LUNG; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FACULTY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; POSTMENOPAUSE; PROGESTINS; PROPORTIONAL HAZARDS MODELS; SMOKING;

EID: 84905124893     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103735     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Ayeni O, Robinson A (2009) Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed? Curr Oncol 16: 21-25.
3. Huang B, Carloss H, Wyatt SW, Riley E (2009) Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population. Cancer 115: 4167-4175.
4. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, et al. (2007) Lung cancer incidence in never smokers. J Clin Oncol 25: 472-478. (Pubitemid 350002951)
5. Sekine I, Sumi M, Ito Y, Tanai C, Nokihara H, et al. (2009) Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy. Jpn J Clin Oncol 39: 707-712.
6. Thomas L, Doyle LA, Edelman MJ (2005) Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 128: 370-381. (Pubitemid 40994497)
7. Henschke CI, Yip R, Miettinen OS (2006) Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. Jama 296: 180-184. (Pubitemid 44050371)
8. Siegfried JM (2001) Women and lung cancer: does oestrogen play a role? Lancet Oncol 2: 506-513.
9. Subramanian J, Govindan R (2007) Lung cancer in never smokers: a review. J Clin Oncol 25: 561-570. (Pubitemid 350002964)
10. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A (2006) Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 24: 59-63. (Pubitemid 46630494)
11. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR (2004) Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 10: 113-123. (Pubitemid 38114169)
12. Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, et al. (2009) Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 374: 1243-1251.
13. Ettinger B, Friedman GD, Bush T, Quesenberry CP, Jr. (1996) Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87: 6-12. (Pubitemid 26015941)
14. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, et al. (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Jama 288: 58-66. (Pubitemid 34705519)
15. Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, et al. (2010) Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 102: 1413-1421.
16. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, et al. (2004) Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev 13: 405-411. (Pubitemid 38737466)
17. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, et al. (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13: 625-635. (Pubitemid 35001770)
18. Kovacs EJ (2005) Aging, traumatic injury, and estrogen treatment. Exp Gerontol 40: 549-555.
19. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M (2010) Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKbeta- and JNK1-Dependent Inflammation. Cancer Cell 17: 89-97.
20. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759. (Pubitemid 41400849)
21. Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, et al. (2008) Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res 14: 4417-4426.
22. Flototto T, Djahansouzi S, Glaser M, Hanstein B, Niederacher D, et al. (2001) Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33: 451-457. (Pubitemid 32881890)
23. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, et al. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18: 4608-4618. (Pubitemid 29415516)
24. Meireles SI, Esteves GH, Hirata R Jr., Peri S, Devarajan K, et al. (2010) Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue. Cancer Prev Res (Phila) 3: 707-717.